Your session is about to expire
← Back to Search
Dietary Supplement
Dietary supplement for Premenstrual Syndrome
N/A
Waitlist Available
Led By Susanne Mitschke
Research Sponsored by Your Super, INC.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This is an open-label observational single-group clinical trial to study the efficacy of a commercially available dietary supplement and its effect on common PMS and menstrual symptoms, as well as health-related biomarkers.
Eligible Conditions
- Premenstrual Syndrome
- Menstrual Cramps
- Menstrual Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in perceived discomfort associated with menstruation
Secondary outcome measures
Change in blood biomarkers: C-reactive protein
Changes in saliva cortisol levels
Trial Design
1Treatment groups
Experimental Treatment
Group I: Dietary supplementExperimental Treatment1 Intervention
Dietary supplement: Moon Balance
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Moon Balance
2022
N/A
~40
Find a Location
Who is running the clinical trial?
CitruslabsIndustry Sponsor
68 Previous Clinical Trials
3,807 Total Patients Enrolled
5 Trials studying Premenstrual Syndrome
270 Patients Enrolled for Premenstrual Syndrome
Your Super, INC.Lead Sponsor
1 Previous Clinical Trials
38 Total Patients Enrolled
Susanne MitschkePrincipal InvestigatorCitruslabs
6 Previous Clinical Trials
343 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger